Status:
COMPLETED
Melatonin Supplementation for Delirium Prevention in Acutely Hospitalized Elderly
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
University of Western Ontario, Canada
Conditions:
Delirium
Eligibility:
All Genders
65+ years
Phase:
PHASE3
Brief Summary
122 people over 70 who were admitted to hospital were enrolled to the study. Half got .5 mg a night of melatonin, half got a placebo.
Eligibility Criteria
Inclusion
- Age over 65 admitted through the emergency department to an internal medicine service in London, Ontario, Canada.
Exclusion
- Life expectancy less than 24 hours,
- Unable to communicate in English,
- Unable to take oral medications,
- Intracranial bleed or known seizure disorder,
- Markedly sub or supra-therapeutic INR while on warfarin, OR
- A known allergy to study tablet ingredients.
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT00873379
Start Date
October 1 2007
End Date
March 1 2008
Last Update
July 7 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre
London, Ontario, Canada, n6a5a5